1. Home
  2. LFVN vs XFOR Comparison

LFVN vs XFOR Comparison

Compare LFVN & XFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFVN
  • XFOR
  • Stock Information
  • Founded
  • LFVN N/A
  • XFOR 2014
  • Country
  • LFVN United States
  • XFOR United States
  • Employees
  • LFVN N/A
  • XFOR N/A
  • Industry
  • LFVN Biotechnology: Pharmaceutical Preparations
  • XFOR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LFVN Health Care
  • XFOR Health Care
  • Exchange
  • LFVN Nasdaq
  • XFOR Nasdaq
  • Market Cap
  • LFVN 269.4M
  • XFOR 118.4M
  • IPO Year
  • LFVN N/A
  • XFOR N/A
  • Fundamental
  • Price
  • LFVN $15.63
  • XFOR $0.30
  • Analyst Decision
  • LFVN Strong Buy
  • XFOR Strong Buy
  • Analyst Count
  • LFVN 2
  • XFOR 3
  • Target Price
  • LFVN $30.50
  • XFOR $3.50
  • AVG Volume (30 Days)
  • LFVN 226.6K
  • XFOR 1.4M
  • Earning Date
  • LFVN 05-01-2025
  • XFOR 05-06-2025
  • Dividend Yield
  • LFVN 1.04%
  • XFOR N/A
  • EPS Growth
  • LFVN 139.37
  • XFOR N/A
  • EPS
  • LFVN 0.56
  • XFOR N/A
  • Revenue
  • LFVN $212,152,000.00
  • XFOR $1,123,000.00
  • Revenue This Year
  • LFVN $22.17
  • XFOR N/A
  • Revenue Next Year
  • LFVN $8.73
  • XFOR $469.50
  • P/E Ratio
  • LFVN $27.36
  • XFOR N/A
  • Revenue Growth
  • LFVN 0.57
  • XFOR N/A
  • 52 Week Low
  • LFVN $5.22
  • XFOR $0.26
  • 52 Week High
  • LFVN $27.38
  • XFOR $1.60
  • Technical
  • Relative Strength Index (RSI)
  • LFVN 34.35
  • XFOR 29.77
  • Support Level
  • LFVN $14.88
  • XFOR $0.34
  • Resistance Level
  • LFVN $17.48
  • XFOR $0.38
  • Average True Range (ATR)
  • LFVN 1.11
  • XFOR 0.04
  • MACD
  • LFVN -0.17
  • XFOR -0.01
  • Stochastic Oscillator
  • LFVN 10.00
  • XFOR 0.32

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

About XFOR X4 Pharmaceuticals Inc.

X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

Share on Social Networks: